AstraZeneca Wang Lei: Continue to increase investment in research and development and medical innovation in China
阿豆学长长ov
发表于 2023-11-5 17:09:09
262
0
0
Wang Lei, Global Executive Vice President and President of International Business and China at AstraZeneca, stated that over the past five years, relying on the advantages of China's large market, CIIE has made positive contributions to accelerating the construction of a new development pattern and promoting world economic development. Through the CIIE, AstraZeneca deeply felt the signal of China's adherence to opening-up and continued support for economic globalization, as well as its responsible image as a major country.
Wang Lei stated that AstraZeneca, as an old friend of CIIE, has participated in six consecutive exhibitions this year. Relying on the strong influence and spillover effects of the CIIE platform, AstraZeneca will announce the latest progress in investment in China at this CIIE, continue to increase investment in China, including research and development, medical innovation, and promote production and supply layout. AstraZeneca will also work with cross-border partners to continuously assist Chinese enterprises and innovative achievements in accelerating their "going global" journey, creating a "global new" with "China's new" approach, promoting the sustainable development of healthcare and contributing to the cause of human health.
Wang Lei stated that history has proven that the Chinese economy is a very stable development ship, and China is one of the largest markets in the world. AstraZeneca will use a more determined belief to play a role as a link and bridge, deepening its long-term commitment to "rooted in China, serving China, and benefiting the world".
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- The big news of "weight loss miracle drug"! Oral Smegglutide Approved for Market in China
- Industry shock! Alibaba Cloud suddenly announced the largest price reduction in history!
- Continuously focusing on content and increasing AI investment in iQiyi's current year
- Novo Nordisk's new weight loss oral medication is applying for clinical efficacy or surpassing smeglutide in China
- How effective is the drug supply process initiated by Novo Nordisk for the approved slimming version of Smegglutide in China?
- "Weight loss pills" are sold in limited quantities in China? Novo Nordisk's latest response
- Yizi International expands its business in China and adds equity investment in Enxi Village
- Yizi International further expands its business in China and significantly increases its equity investment in Enxi Village
- Yizi International further expands its business in China and significantly increases its equity investment in Enxi Village
- China International Import Expo opens listening mode, 'all students' look forward to the prospects of the Chinese market
-
11月21日、2024世界インターネット大会烏鎮サミットで、創業者、CEOの周源氏が大会デジタル教育フォーラムとインターネット企業家フォーラムでそれぞれ講演、発言したことを知っている。周源氏によると、デジタル教 ...
- 不正经的工程师
- 昨天 16:36
- 支持
- 反对
- 回复
- 收藏
-
アリババは、26億5000万ドルのドル建て優先無担保手形と170億元の人民元建て優先無担保手形の定価を発表した。ドル債の発行は2024年11月26日に終了する予定です。人民元債券の発行は2024年11月28日に終了する予定だ ...
- SOGO
- 3 天前
- 支持
- 反对
- 回复
- 收藏
-
スターバックスが中国事業の株式売却の可能性を検討していることが明らかになった。 11月21日、外国メディアによると、スターバックスは中国事業の株式売却を検討している。関係者によると、スターバックスは中国事 ...
- 献世八宝掌
- 前天 16:29
- 支持
- 反对
- 回复
- 收藏
-
【意法半導体CEO:中国市場は非常に重要で華虹と協力を展開】北京時間11月21日、意法半導体(STM.N)は投資家活動の現場で、同社が中国ウェハー代工場の華虹公司(688347.SH)と協力していると発表した。伊仏半導体 ...
- 黄俊琼
- 前天 14:29
- 支持
- 反对
- 回复
- 收藏